Itchy Pigmented Lesions on the Upper Back

  • Niharika Ranjan Lal
Part of the Clinical Cases in Dermatology book series (CLIDADE)


Macular amyloidosis is a common primary localized cutaneous amyloidosis developing due to deposition of keratinocytes-derived amyloid proteins in previously normal appearing skin. A 40-year-old lady presented with itchy hyperpigmented macules and patches on the upper back and upper extremities of 2 years duration. The lesions were arranged in a characteristic rippled pattern. Dermoscopy showed the presence of brown clods with radiating brown lines, in a “Hub and Spoke” pattern. The diagnosis of macular amyloidosis was confirmed on histopathology by demonstrating eosinophilic, amorphous deposits in papillary dermis which stain positive for amyloid with Congo red stain. Treatment is often disappointing and topical corticosteroids, 10% dimethylsulphoxide (DMSO), acitretin and dermabrasion have been tried with variable success.


Primary localized cutaneous amyloidosis Macular amyloidosis Amyloid protein Hub and Spoke pattern Congo red Dimethylsulphoxide 


  1. 1.
    Bandhlish A, Aggarwal A, Koranne RV. A clinico-epidemiological study of macular amyloidosis from north India. Indian J Dermatol. 2012;57(4):269–74.CrossRefGoogle Scholar
  2. 2.
    Mehrotra K, Dewan R, Kumar JV, Dewan A. Primary cutaneous amyloidosis: a clinical, histopathological and immunofluorescence study. J Clin Diagn Res. 2017;11(8):WC01–5.PubMedPubMedCentralGoogle Scholar
  3. 3.
    Steciuk A, Dompmartin A, Troussard X, Verneuil L, Macro M, Comoz F, et al. Cutaneous amyloidosis and possible association with systemic amyloidosis. Int J Dermatol. 2002;41(3):127–32.CrossRefGoogle Scholar
  4. 4.
    Eswaramoorthy V, Kaur I, Das A, Kumar B. Macular amyloidosis: etiological factors. J Dermatol. 1999;26:305–10.CrossRefGoogle Scholar
  5. 5.
    Vijaya B, Dalal BS, Sunila, Manjunath GV. Primary cutaneous amyloidosis: a clinico-pathological study with emphasis on polarized microscopy. Indian J Pathol Microbiol. 2012;55:170–4.CrossRefGoogle Scholar
  6. 6.
    Robles-Méndez JC, Rizo-Frías P, Herz-Ruelas ME, Pandya AG, Ocampo Candiani J. Lichen planus pigmentosus and its variants: review and update. Int J Dermatol. 2018;57:505–14.CrossRefGoogle Scholar
  7. 7.
    Howard M, Sahhar L, Andrews F, Bergman R, Gin D. Notalgia paresthetica: a review for dermatologists. Int J Dermatol. 2018;57(4):388–92.CrossRefGoogle Scholar
  8. 8.
    Katoulis AC, Stavrianeas NG, Panayiotides JG, Bozi E, Vamvasakis E, Kalogeromitros D, et al. Poikiloderma of Civatte: a histopathological and ultrastructural study. Dermatology. 2007;214(2):177–82.CrossRefGoogle Scholar
  9. 9.
    Weidner T, Illing T, Elsner P. Primary localized cutaneous amyloidosis: a systematic treatment review. Am J Clin Dermatol. 2017;18(5):629–42.CrossRefGoogle Scholar
  10. 10.
    Das J, Gogoi RK. Treatment of primary localised cutaneous amyloidosis with cyclophosphamide. Indian J Dermatol Venereol Leprol. 2003;69:163–4.PubMedGoogle Scholar
  11. 11.
    Ostovari N, Mohtasham N, Oadras MS, Malekzad F. 532-nm and 1064-nm Q-switched Nd:YAG laser therapy for reduction of pigmentation in macular amyloidosis patches. J Eur Acad Dermatol Venereol. 2008;22:442–6.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Niharika Ranjan Lal
    • 1
  1. 1.ESI PGIMSR and ESI Medical CollegeKolkataIndia

Personalised recommendations